Óscar Núñez

Profesor asociado Facultad de Medicina

Universidad CEU San Pablo

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Óscar Núñez is an Associate Professor at the Facultad de Medicina, Universidad CEU San Pablo in Spain. His research primarily focuses on the management and treatment of Helicobacter pylori infection, including topics such as antibiotic resistance and the effectiveness of various treatment regimens. Recent publications include studies on the safety and efficacy of quadruple therapies and nationwide surveys regarding H. pylori management practices.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (6)

Perminder Phull

University of Aberdeen

UNITED KINGDOM

View details

Luis Bujanda

University of the Basque Country/Euskal Herriko Unibertsitatea (UPV/EHU)

SPAIN

View details

Luis Fernández-Salazar

Associate Professor

Universidad de Valladolid

SPAIN

View details

Sinead Smith

Assistant Professor

Trinity College Dublin

IRELAND

View details

Manuel Pabón Carrasco

Universidad de Sevilla

SPAIN

View details

Giuseppe Losurdo

Università degli Studi di Bari

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Óscar Núñez

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Effectiveness and Safety of First‐Line Non‐Bismuth Quadruple Concomitant Therapy Versus Single‐Capsule Bismuth Quadruple Therapy

Management of <i>Helicobacter pylori</i> Infection in Spain Beyond the Data Collected in the European Registry on <i>H. pylori</i> Management (Hp‐<scp>EuReg</scp>): Results of a Nationwide Survey

Indications of <i>Helicobacter pylori</i> Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp‐<scp>EuReg</scp>)

Effectiveness of Helicobacter pylori Treatments According to Antibiotic Resistance

Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for<i>Helicobacter pylori</i>infection between 2013 and 2021: results from the European registry on<i>H. pylori</i>management (Hp-EuReg)

INTRAGASTRIC BALLOON TO TREAT OBESITY. AN OLD FRIEND WITH NEW HORIZONS. ABOUT THE FIRST SPANISH DEVICE (STELLA�).

Bismuth quadruple three-in-one single capsule three times a day increases effectiveness compared with the usual four times a day schedule: results from the European Registry on<i>Helicobacter pylori</i>Management (Hp-EuReg)

Role of proton pump inhibitors dosage and duration in <i>Helicobacter pylori</i> eradication treatment: Results from the European Registry on <i>H. pylori</i> management

Empirical rescue treatment of<i>Helicobacter pylori</i>infection in third and subsequent lines: 8-year experience in 2144 patients from the European Registry on<i>H. pylori</i>management (Hp-EuReg)

Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)

Collaborators (6)

Perminder Phull

Luis Bujanda

Luis Fernández-Salazar

Sinead Smith

Manuel Pabón Carrasco

Giuseppe Losurdo

Make your next move.